Literature DB >> 29359800

WT1 mRNA level reflects disease changes and progression of myelodysplastic syndromes patients with 'stable disease'.

Xin Du1,2, Suxia Geng1, Jianyu Weng1, Chengxin Deng1, Zesheng Lu1, Minming Li1, Ping Wu1, Peilong Lai1.   

Abstract

Entities:  

Keywords:  Wilms tumour gene; hypomethylating agents; myelodysplastic syndromes; stable disease

Mesh：

Substances：

Year:  2018        PMID： 29359800     DOI： 10.1111/bjh.15098

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 Patients.

Authors:  MinMing Li; Chao Li; SuXia Geng; XiaoMei Chen; Ping Wu; ChengXin Deng; XiaoFang Chen; ZeSheng Lu; JianYu Weng; Xin Du
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

2.  Prognostic impact of peripheral blood Wilms' tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis.

Authors:  Tomoya Maeda; Akira Matsuda; Chie Asou; Daisuke Okamura; Ken Tanae; Mika Kohri; Maho Ishikawa; Naoki Takahashi; Kunihiro Tsukasaki; Nobutaka Kawai; Norio Asou; Masami Bessho
Journal:  Leuk Res Rep       Date:  2020-12-08

3.  Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML.

Authors:  Juliette Lambert; Jerome Lambert; Xavier Thomas; Alice Marceau-Renaut; Jean-Baptiste Micol; Aline Renneville; Emmanuelle Clappier; Sandrine Hayette; Christian Récher; Emmanuel Raffoux; Arnaud Pigneux; Celine Berthon; Christine Terré; Karine Celli-Lebras; Sylvie Castaigne; Nicolas Boissel; Philippe Rousselot; Claude Preudhomme; Hervé Dombret; Nicolas Duployez
Journal:  Blood Adv       Date:  2021-12-14

4.  Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS.

Authors:  Christina Rautenberg; Ulrich Germing; Sabrina Pechtel; Marius Lamers; Carolin Fischermanns; Paul Jäger; Stefanie Geyh; Rainer Haas; Guido Kobbe; Thomas Schroeder
Journal:  Blood Cancer J       Date:  2019-11-12       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.